Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 2 years
- Director since
- 2024
2 years of board service in total across 1 board, counting each seat separately. Longest: Abeona Therapeutics Inc., 2 years.
Abeona Therapeutics Inc.
Director
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| May 15, 2026 | Abeona Therapeutics Inc. | Open-market sale | −26,143 | $5.53 | $144,571 |
| May 5, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −344 | $24.96 | $8,586 |
| Apr 16, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +34,674 | — | — |
| Mar 2, 2026 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −7,029 | $22.80 | $160,261 |
| Mar 1, 2026 | Ultragenyx Pharmaceutical Inc. | Grant or award | +11,643 | — | — |
| Feb 2, 2026 | Abeona Therapeutics Inc. | Open-market sale | −16,284 | $5.09 | $82,886 |
| Jan 26, 2026 | Abeona Therapeutics Inc. | Grant or award | +37,313 | — | — |
| Aug 14, 2025 | Abeona Therapeutics Inc. | Open-market sale | −4,718 | $6.93 | $32,696 |
| May 5, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −520 | $39.24 | $20,405 |
| Apr 21, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −242 | $35.11 | $8,497 |
| Mar 3, 2025 | Ultragenyx Pharmaceutical Inc. | Open-market sale | −8,945 | $42.10 | $376,585 |
| Mar 1, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +16,813 | — | — |
| Mar 1, 2025 | Ultragenyx Pharmaceutical Inc. | Grant or award | +14,971 | — | — |
| Jan 31, 2025 | Abeona Therapeutics Inc. | Grant or award | +36,101 | — | — |
| Aug 13, 2024 | Abeona Therapeutics Inc. | Grant or award | +11,044 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.